Chiyi Jiang, Yeran Yang, Wenfa Yang, Xiaoli Ma, Ping Chu, Chao Duan, Xinyu Wang, Binglin Jian, Wen Zhao, Sidou He, Xisi Wang, Shihan Zhang, Qian Zhao, Peiyi Yang, Cheng Huang, Geng Ma, Yan Su, Yongli Guo
BACKGROUND: With the development of the novel coronavirus disease 2019 (COVID-19), China implemented measures in an attempt to control the infection rate. We conducted a single-center, cross-sectional study to ascertain the impact of the COVID-19 pandemic on the equitable availability of medical resources for children diagnosed with malignant solid tumors in China. METHODS: Data on the demographics, clinical characteristics, and medical expenses of 876 patients diagnosed with neuroblastoma, rhabdomyosarcoma (RMS), Wilms tumor, hepatoblastoma (HB), Ewing sarcoma (ES), and central nervous system (CNS) tumors from 2019 to 2021, during the COVID-19 pandemic, were retrospectively collected from the National Center for Children's Health...
March 27, 2024: Translational Pediatrics